Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement
The IMID Forum
- Published
- June 18, 2026
- Duration
- 13:03
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examinin…
Summary
Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis. This month’s conversation explores how patients with differing levels of baseline disease activity may require different degrees of improvement before perceiving treatment benefit…
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis. This month’s conversation explores how patients with differing levels of baseline disease activity may require different degrees of improvement before perceiving treatment benefit, highlighting the potential for more personalised treatment targets and shared decision making in PsA.